Blood Leukocyte Signaling Pathways as Predictors of Severity of Acute Pancreatitis.


Journal

Pancreas
ISSN: 1536-4828
Titre abrégé: Pancreas
Pays: United States
ID NLM: 8608542

Informations de publication

Date de publication:
Historique:
pubmed: 22 5 2021
medline: 19 1 2022
entrez: 21 5 2021
Statut: ppublish

Résumé

Clinical practice lacks biomarkers to predict the severity of acute pancreatitis (AP). We studied if intracellular signaling of circulating leukocytes could predict persistent organ dysfunction (OD) and secondary infections in AP. A venous blood sample was taken from 174 patients with AP 72 hours or less from onset of symptoms and 31 healthy controls. Phosphorylation levels (p) of appropriately stimulated signal transducer and activator of transcription 1 (STAT1), STAT6, nuclear factor-κB (NF-κB), Akt, and nonstimulated STAT3 in monocytes, neutrophils, and lymphocytes was measured using phosphospecific flow cytometry. The patients showed higher pSTAT3 and lower pSTAT1, pSTAT6, pNF-κB, and pAkt than healthy controls. pSTAT3 in all leukocyte subtypes studied increased, and pSTAT1 in monocytes and T cells decreased in an AP severity-wise manner. In patients without OD at sampling, high pSTAT3 in monocytes and T lymphocytes were associated with development of persistent OD. In patients with OD, low interleukin-4-stimulated pSTAT6 in monocytes and neutrophils and Escherichia coli-stimulated pNF-κB in neutrophils predicted OD persistence. High pSTAT3 in monocytes, CD8+ T cells, and neutrophils; low pSTAT1 in monocytes and T cells; and low pNF-κB in lymphocytes predicted secondary infections. Leukocyte STAT3, STAT1, STAT6, and NF-κΒ phosphorylations are potential predictors of AP severity.

Identifiants

pubmed: 34016897
doi: 10.1097/MPA.0000000000001832
pii: 00006676-900000000-98255
pmc: PMC8195735
doi:

Substances chimiques

Biomarkers 0
NF-kappa B 0
STAT Transcription Factors 0
STAT1 Transcription Factor 0
STAT1 protein, human 0
STAT3 Transcription Factor 0
STAT3 protein, human 0
STAT6 Transcription Factor 0
STAT6 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

710-718

Informations de copyright

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

PLoS One. 2015 Sep 09;10(9):e0137385
pubmed: 26353115
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Ann Clin Lab Sci. 2016 Winter;46(1):54-9
pubmed: 26927343
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13487-91
pubmed: 23898202
Cytokine Growth Factor Rev. 2016 Oct;31:1-15
pubmed: 27185365
Br J Surg. 2006 Jun;93(6):738-44
pubmed: 16671062
J Infect Dis. 2000 Mar;181(3):1055-61
pubmed: 10720531
Scand J Gastroenterol. 2001 Oct;36(10):1100-7
pubmed: 11589386
World J Gastroenterol. 2014 Dec 7;20(45):16935-47
pubmed: 25493006
Cell Mol Biol Lett. 2018 Oct 31;23:52
pubmed: 30410547
J Immunol. 2018 May 15;200(10):3547-3555
pubmed: 29626088
Biochimie. 2010 May;92(5):425-44
pubmed: 20159032
BMC Immunol. 2010 May 27;11:26
pubmed: 20507572
Int J Clin Exp Med. 2015 May 15;8(5):7430-4
pubmed: 26221286
J Biol Chem. 2003 Feb 7;278(6):3903-11
pubmed: 12459556
Crit Care Med. 1995 Oct;23(10):1638-52
pubmed: 7587228
Gastroenterology. 2008 Sep;135(3):816-20
pubmed: 18616944
Gut. 2008 Feb;57(2):259-67
pubmed: 17675325
Alcohol Clin Exp Res. 2008 Sep;32(9):1565-73
pubmed: 18616672
Scand J Immunol. 2017 Feb;85(2):155-161
pubmed: 27992958
Crit Care. 2010;14(6):R207
pubmed: 21087472
World J Gastroenterol. 2010 Jun 21;16(23):2867-72
pubmed: 20556831
J Immunol. 2007 May 1;178(9):5940-8
pubmed: 17442978
Pancreatology. 2013 Mar-Apr;13(2):118-24
pubmed: 23561969
Scand J Immunol. 2018 Feb;87(2):88-98
pubmed: 29193197
Shock. 2012 Nov;38(5):515-23
pubmed: 23042197
Cell Signal. 2009 Feb;21(2):246-52
pubmed: 18992325
Crit Care Med. 2010 Aug;38(8):1702-8
pubmed: 20512034
Crit Care. 2011;15(1):108
pubmed: 21349138
Cell. 2007 Sep 7;130(5):918-31
pubmed: 17803913
Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L868-L880
pubmed: 27638904
Cell Rep. 2014 Dec 24;9(6):2112-23
pubmed: 25497086
Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):
pubmed: 28620096
Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1963-9
pubmed: 15319270
Lancet Gastroenterol Hepatol. 2016 Sep;1(1):45-55
pubmed: 28404111
Crit Care Med. 2009 May;37(5):1729-34
pubmed: 19325483

Auteurs

Antti Turunen (A)

From the Abdominal Center, Department of Abdominal Surgery.

Antti Kuuliala (A)

Bacteriology and Immunology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Harri Mustonen (H)

From the Abdominal Center, Department of Abdominal Surgery.

Pauli Puolakkainen (P)

From the Abdominal Center, Department of Abdominal Surgery.

Leena Kylänpää (L)

From the Abdominal Center, Department of Abdominal Surgery.

Krista Kuuliala (K)

Bacteriology and Immunology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH